On September 11th, Foundation Chairman Neal F. Kassell, MD and Scientific Director Jessica Foley, PhD participated in a focused ultrasound panel discussion at the Virginia Biotechnology Association's Commercialization luncheon event in Richmond. More than 100 people were in attendance for the presentation, which garnered the attention of the Richmond Times Dispatch. Their feature story entitled "Focused Ultrasound has the Potential to Improve Treatment for Some Conditions" was the headline on the Business News page. The story informed readers about the technology's current uses and future possibilities.
A video of the discussion (approximately 55 minutes) is available. Virginia Bio advocates for its more than 200 biopharmaceutical and device industry members on federal, state, and local issues.